Clinical data | |
---|---|
Trade names | Norvedan |
AHFS/ Drugs.com | International Drug Names |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard ( EPA) | |
ECHA InfoCard | 100.038.129 |
Chemical and physical data | |
Formula | C17H12ClNO2S |
Molar mass | 329.80 g·mol−1 |
3D model ( JSmol) | |
Melting point | 162–163 °C (324–325 °F) |
| |
| |
(what is this?) (verify) |
Fentiazac is a thiazole-based nonsteroidal anti-inflammatory drug (NSAID) developed for use in joint and muscular pain. [1] Like most other NSAIDs, it acts through inhibition of prostaglandin synthesis, via non-selective inhibition of both COX-1 and COX-2. First described in 1974, it was synthesized using the Hantzsch thiazole synthesis. [2]
Fentiazac was marketed under the trade-name Norvedan (among others), but its market status is currently unknown and assumed to be discontinued. [3]
Clinical data | |
---|---|
Trade names | Norvedan |
AHFS/ Drugs.com | International Drug Names |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard ( EPA) | |
ECHA InfoCard | 100.038.129 |
Chemical and physical data | |
Formula | C17H12ClNO2S |
Molar mass | 329.80 g·mol−1 |
3D model ( JSmol) | |
Melting point | 162–163 °C (324–325 °F) |
| |
| |
(what is this?) (verify) |
Fentiazac is a thiazole-based nonsteroidal anti-inflammatory drug (NSAID) developed for use in joint and muscular pain. [1] Like most other NSAIDs, it acts through inhibition of prostaglandin synthesis, via non-selective inhibition of both COX-1 and COX-2. First described in 1974, it was synthesized using the Hantzsch thiazole synthesis. [2]
Fentiazac was marketed under the trade-name Norvedan (among others), but its market status is currently unknown and assumed to be discontinued. [3]